(Q44956452)

7 December 2017

title

Positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual Hodgkin's disease mediastinal masses (English)

1 reference

positron emission tomography

7 December 2017

main subject

1 reference

based on heuristic

inferred from title

author

María J García-Velloso

0 references

author name string

Carlos Panizo

1

1 reference

7 December 2017

Marta Pérez-Salazar

2

1 reference

7 December 2017

Maurizio Bendandi

3

1 reference

7 December 2017

Mercedes Rodríguez-Calvillo

4

1 reference

7 December 2017

José Francisco Boán

5

1 reference

7 December 2017

María José García-Velloso

6

1 reference

7 December 2017

José Richter

7

1 reference

7 December 2017

Eduardo Rocha

8

1 reference

7 December 2017

publication date

1 September 2004

1 reference

7 December 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Leukemia & Lymphoma

1 reference

7 December 2017

volume

45

1 reference

7 December 2017

issue

9

1 reference

7 December 2017

page(s)

1829-1833

1 reference

Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000223813

10.1080/1042819042000223813

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference